Schedule 13G ownership disclosure

QUINCE THERAPEUTICS INC

Security class unavailable · CUSIP: 22053A107

Event date: 2024-09-30

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
0.0000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001214659-24-019112
Form type
SC 13G/A
Filer
Quince Therapeutics, Inc.
CIK
CIK 1662774
Filed
Nov 14, 2024
Reporting period
Sep 30, 2024
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub